A Notice of FDA Action is an official U.S. Food and Drug Administration import record used to communicate FDA actions for an entry or entry line. If you have a real notice—or an FDA/ITACS state you have independently verified—the first task is to identify the latest applicable action for the specific line, not to translate the whole shipment into one generic “FDA hold.”
The states are materially different. Examination or Sample, Detained, Released, and Refused are not interchangeable. A notice saying Detained/May be Destroyed does not mean destruction has already happened. A Detained FDA action does not, by itself, establish a separate CBP seizure. And FDA’s regulatory decision does not tell you, by itself, which carrier, postal operator, warehouse, broker, or government facility physically has the goods at that moment.
For a detention, read the respond by timeframe on your current Notice of FDA Action. Do not replace it with a generic “10-day rule” found online. FDA’s public guidance describes a general timing framework, but the notice-specific timeframe is the user-facing clock for that entry. If FDA grants an extension, FDA says the new timeframe should be reflected in a new Notice of FDA Action.
The official route also depends on the state. Use ITACS to check FDA entry/line status where you have the required Customs entry number. For an entry under initial review, pending review, or documents requested, FDA’s current contact guidance routes questions to the FDA ImportShield Program (FISP). For a Detained or Refused entry, FDA directs questions to the Compliance Officer listed on the last page of the current Notice of FDA Action.
Quick state guide
| FDA evidence | What it confirms | What it does not confirm |
|---|---|---|
| Initial review / documents requested | FDA review is still open and the entry may need information before an admissibility decision. | Detention, refusal, release, or a CBP seizure. |
| Examination / Sample | FDA selected the relevant entry or line for examination or sample collection. | That FDA found a violation; that the line is already Detained or Refused; a universal exam-completion deadline. |
| Detained | FDA entered its detention-and-hearing process for the specified line and identified the apparent violation or charges plus an opportunity to respond. | Final refusal; a CBP seizure or forfeiture case; who physically possesses the goods at that moment. |
| Detained / May be Destroyed | Detention exists and a special future administrative-destruction branch may apply if the shipment fits that authority. | That destruction already happened; that destruction is inevitable; that every FDA-regulated product is eligible for that branch. |
| Released | FDA released the specified entry line at that import stage. | Universal compliance for every legal purpose; acceptance of future imports; that the parcel is already moving, out for delivery, or delivered. |
| Refused | FDA made its final admissibility decision for the refused line under the FDA import process. | CBP forfeiture; that return/export has already occurred; that destruction has already occurred; the seller, marketplace, or refund outcome. |
These actions do not have to occur as one mandatory linear sequence. FDA may release a line after review, select a line for examination or sampling, detain a line, later release it, or later refuse it. Different lines under the same entry can also have different FDA actions.
Read the latest applicable notice and line
FDA’s import operating architecture uses the Notice of FDA Action for multiple line-level actions, including sampling, detention, release, and refusal. FDA may issue another notice when the action for a line changes.
That creates a simple evidence rule:
Use the latest applicable FDA action for the specific entry line. Do not let an older notice, a seller message, or a carrier tracking phrase override a later official FDA action.
For example:
- an earlier examination notice does not remain the controlling state after FDA later issues a Released action for that line;
- a Detained action is not automatically a Refused action;
- one released line does not prove that every other line in the entry has been released.
ITACS can show FDA-regulated entry and line status. With account functionality, it can also distribute or provide downloads of Notices of FDA Action. ITACS account eligibility is not universal, and an ITACS account is not required simply to import FDA-regulated goods.
If the only evidence you have is a generic carrier status such as “customs,” “government hold,” or “clearance delay,” and no formal FDA object or independently verified FDA state controls the case, use Package Stuck in Customs instead.
What Examination or Sample means
An FDA examination or sample-collection state is distinct from detention.
It confirms that FDA selected the relevant entry or line for examination or sampling. FDA’s current examination guidance also explains that ITACS can be used to provide goods-location information for lines targeted for examination and to view estimated laboratory completion dates for sampled lines.
It does not establish that FDA has already found a violation. It also does not establish that a detention or refusal exists.
There is no universal FDA completion countdown for examination or sampling in the reviewed FDA guidance. FDA states that there is no specific statutory or regulatory requirement that the admissibility examination or sampling process be completed within a set amount of time. That does not erase other shipment, storage, seller, marketplace, or payment deadlines; it only means this page should not invent a universal FDA exam deadline.
If the issue becomes an exact request for ID, invoice, tax number, or another document, move to Customs or Carrier Asks for ID, Tax Number, Invoice, or Proof.
What Detained means
A Notice of FDA Action designated Detained functions as FDA’s Notice of Detention and Hearing for that line. FDA says the notice identifies the apparent violation or charges and provides an opportunity for testimony.
At this stage:
- Detained is not Refused.
- Detained is not, by itself, a CBP seizure.
- Detained does not identify the physical custodian.
A separate CBP seizure process would require separate official evidence. If an authenticated CBP Notice of Detention or Notice of Seizure—not the FDA notice—is now the controlling object, use CBP Detention or Seizure Notice for a Package.
Do not assume that the person expecting the package is automatically the importer of record or the legally responsible respondent. FDA’s detention guidance recognizes the owner, consignee, importer of record, and an authorized representative in the response architecture. In the regulatory context of 21 CFR Part 1 Subpart E, “owner or consignee” is tied to the person making entry as importer of record. For a real shipment, use the notice and entry records to identify the actual role rather than assigning it from the delivery address alone.
This page does not tell you what testimony, laboratory evidence, reconditioning proposal, product argument, or legal position to submit. Those are product- and case-specific compliance questions.
What “Detained / May be Destroyed” means
The phrase Detained/May be Destroyed is prospective. It means a detention exists and the shipment may fall within a special administrative-destruction pathway. It does not mean FDA has already destroyed the goods.
FDA’s current Administrative Destruction Authority is narrow. It applies to certain refused imported drugs and devices coming through international mail and express couriers, currently valued at $2,500 or less, or a higher amount if set by regulation.
That is not the rule for every FDA-regulated product or every refusal.
For a shipment that actually falls into this special branch, later FDA notices control whether the product is released, refused, destroyed, or returned as the applicable authority permits. Do not infer completed destruction from the earlier “May be Destroyed” wording.
What Released means
A Released FDA action records FDA’s release/admissibility outcome for the specified entry line at that stage.
That is significant evidence, but it has an important ceiling:
- it does not prove that every other line in the entry has the same state;
- it does not prove the package has already resumed physical movement;
- it does not prove delivery;
- it should not be treated as a universal assurance that the product complies with every legal requirement or that every future import of the product will be accepted.
If FDA release is established but the package later becomes a carrier or customs-disposition problem, follow the evidence that controls that later state rather than continuing to interpret the old FDA release as a live custody record.
What Refused means
FDA describes Refusal as its final decision that a detained shipment is in violation of FDA laws and regulations. The refusal is therefore a different state from detention.
A Refused notice does not, by itself, establish:
- a CBP forfeiture case;
- that the goods have already been exported;
- that the goods have already been destroyed;
- that a carrier has already returned the parcel;
- any seller, marketplace, refund, or payment decision.
FDA’s general Import Refusals guidance says a refused shipment must be exported or destroyed under FDA and CBP supervision within 90 days from the Notice of FDA Action refusal date. Keep that rule in its proper scope: FDA also has the separate administrative-destruction authority described above for certain refused drugs and devices. Do not flatten those branches into one universal “90 days for every FDA disposition” rule.
When the unresolved problem is no longer the FDA refusal state but the actual return, storage, export, or disposal outcome, use Customs Clearance Failed or Package Became Undeliverable for the physical-disposition problem rather than treating “Refused” as proof that one particular outcome already happened.
FDA, CBP, the carrier, and the importer do different jobs
The most common mistake is to use one actor’s role to answer another actor’s question.
| Actor | What this page uses that actor for | What not to assume |
|---|---|---|
| FDA | FDA-regulated product admissibility and FDA Notice of FDA Action states. | That FDA is necessarily the physical custodian of the parcel. |
| CBP | Border/customs authority and, in some refusal branches, supervision or redelivery/export functions. | That an FDA detention automatically created a CBP seizure case. |
| USPS / express courier / carrier / warehouse | Physical transport, handling, storage, or custody depending on the lane and stage. | That the carrier controls FDA’s admissibility decision. |
| Importer of record / owner / consignee | Entry roles that can matter for FDA notices and response authority. | That the intended recipient is automatically the importer of record. |
| Broker / filer | Entry submission and, often, access to the Customs entry number or entry records. | That the broker owns the FDA admissibility decision. |
| Authorized representative | A person authorized to act for an eligible party in the FDA detention process. | That any recipient, seller, or third party can act without the required authority. |
| Compliance Officer | Notice-specific FDA contact for Detained or Refused entries under current FDA guidance. | That this is the correct route for every pre-detention or initial-review question. |
| Seller / marketplace / payment provider | Separate commercial, refund, dispute, or payment processes. | That FDA review pauses those independent deadlines. |
For international mail, FDA describes a specific chain: USPS receives inbound international mail, presents it to CBP, and CBP may refer FDA-regulated products to FDA for admissibility review. That is an international-mail example. Do not generalize the exact USPS → CBP → FDA chain to express courier or ordinary cargo entries.
Which deadline actually applies?
There is no single FDA countdown that safely answers every state.
Examination or sample
The reviewed FDA source does not establish a universal completion deadline.
Detention
Use the respond by timeframe on the current Notice of FDA Action.
FDA’s current Detention & Hearing page explains a general 10-business-day framework and says notices generally allow calendar time for weekends, holidays, and mailing. But the operational user rule is still to read the actual notice. Do not calculate your deadline from a generic article when the current FDA notice provides the entry-specific timeframe.
FDA also describes an extension-request mechanism if the request is made within the notice-specified timeframe and has a reasonable basis. If FDA grants an extension, FDA says the new timeframe should be stated on a new Notice of FDA Action. This page does not advise whether you should request an extension or what reason will succeed.
Refusal
FDA’s general refusal page currently describes the 90-day export-or-destroy framework from the refusal notice date, subject to the special branches already discussed.
Commercial deadlines
Seller return windows, marketplace case deadlines, payment-provider disputes, refund periods, and card chargeback deadlines are different clocks. An FDA process should not be assumed to pause them.
If those commercial clocks become the highest-risk unresolved issue, use Protect Package Refund, Dispute, and Chargeback Deadlines.
Where to check status and who to contact
Use the official route that matches the current state.
Entry or line status: ITACS
FDA’s ITACS provides trade-facing entry/line status and document functions. FDA’s current shipment-status guidance says you need the shipment’s Customs entry number to use the status lookup. If you do not have that number, FDA directs users to their broker or filer for assistance.
An ITACS account provides additional functions such as electronic Notices of FDA Action, but account eligibility is controlled and is not universal.
Initial review, pending review, or documents requested: FISP
FDA’s current Contact the FDA Import Program page routes questions on entries under initial review—including pending review or documents requested—to the FDA ImportShield Program (FISP).
If the actual blocker is not FDA review but a broker, formal-entry, importer/filer, power-of-attorney, or bond dependency, use Why Does My Package Need a Customs Broker, Formal Entry, or Power of Attorney?.
Detained or Refused: the Compliance Officer on the notice
For a Detained or Refused entry, FDA’s current contact page directs questions to the Compliance Officer listed on the last page of the Notice of FDA Action.
Use the contact on your current notice rather than a phone number or email copied from another shipment or an old article.
11Tracking cannot access ITACS for you, authenticate a private FDA case, submit testimony, contact FDA or CBP on your behalf, clear customs, or create a release.
Import Alert and DWPE are different questions
An FDA detention is not automatically an Import Alert or Detention Without Physical Examination (DWPE) case.
A particular entry can be detained under an Import Alert, but the existence of a detention alone does not establish that cause. Check the actual notice, ITACS state, and any applicable official Import Alert.
There is also a second distinction:
Obtaining release of one shipment from DWPE is not the same task as obtaining removal of a firm or product from an Import Alert for future shipments.
This page stops at that distinction. It does not provide Import Alert removal, private-laboratory, reconditioning, or petition strategy.
What to do now
Use this sequence without trying to solve product-specific compliance inside a tracking-help page:
- Confirm the evidence object. Use this page only when a real Notice of FDA Action or independently verified FDA/ITACS state controls the case.
- Identify the latest applicable entry line. Do not assume the whole shipment has one FDA state.
- Classify the state. Initial review, Examination/Sample, Detained, Detained/May be Destroyed, Released, and Refused lead to different evidence conclusions.
- Read the notice-specific clock. For detention, preserve the
respond bytimeframe from the current notice rather than relying on a generic countdown. - Identify the actual entry role. Do not assume the intended recipient is the importer of record.
- Use the state-specific official route. ITACS for status; FISP for current initial-review routing; the notice-listed Compliance Officer for Detained or Refused entries.
- Keep custody separate from regulatory authority. If you need to know who physically has the parcel, use direct carrier, broker, warehouse, CBP, or other shipment evidence instead of inferring custody from the FDA action alone.
- Protect independent commercial clocks. Preserve seller, marketplace, refund, payment, and chargeback deadlines separately.
- Exit this page when a narrower problem becomes primary. FDA state classification should not absorb customs-document, payment, broker, assessment, CBP-seizure, physical-disposition, or legal/compliance strategy.
When another 11Tracking guide is the better owner
Use the strongest observable evidence to move to the narrower owner:
- No formal FDA object; generic customs review is still the problem: Package Stuck in Customs.
- A formal CBP detention or seizure notice controls: CBP Detention or Seizure Notice for a Package.
- The unresolved task is an exact ID, tax number, invoice, or proof request: Customs or Carrier Asks for ID, Tax Number, Invoice, or Proof.
- The blocker is broker, formal entry, importer/filer, POA, or bond architecture: Customs Broker, Formal Entry, or Power of Attorney.
- A declaration, HS code, value, origin, description, or invoice mismatch becomes primary: Customs Declaration, HS Code, Value, or Invoice Mismatch.
- A customs-related payment demand becomes primary: Customs Fee, Duty, Tax, Brokerage, or Release Payment Request.
- The dispute is the amount of an authentic government customs assessment: Customs Duty or Import Tax Amount Looks Wrong.
- The unresolved issue is return, storage, export, or disposal after clearance failure/refusal: Customs Clearance Failed or Package Became Undeliverable.
- The FDA-specific state is already understood and the remaining problem is simply choosing the responsible actor: Who Should I Contact About a Package?.
- Seller, marketplace, refund, payment, or chargeback deadlines are now the main risk: Protect Package Refund, Dispute, and Chargeback Deadlines.
If the unresolved question is what product-specific evidence to submit, whether a drug/device/food/cosmetic is admissible, whether to use a personal-importation exception, how to recondition goods, how to challenge an Import Alert, or which legal response strategy to choose, this 11Tracking page has reached its boundary. Use the current FDA product/program authority, broker or filer where appropriate, or qualified professional advice for the specific compliance/legal question.
Protect private case information
Keep shipment-specific government and commercial evidence private unless an official process requires it.
Do not post publicly:
- Customs entry numbers;
- Notice of FDA Action or case identifiers;
- importer numbers;
- home or business addresses;
- identity documents;
- medical or prescription details;
- private invoices;
- ITACS, broker, carrier, marketplace, or payment credentials.
Use official FDA, CBP, broker/filer, carrier, seller, marketplace, or payment-provider channels for sensitive records. 11Tracking does not need those private records to explain the state model on this page.